Skip to main content

Table 2 Univariate comparison of clinical variables among patients with good prognosis and poor prognosis

From: Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

 

Alive (n = 121)

Deceased (n = 38)

P value

Proportion of patients with poor prognosis score (%)

0.34

0.74

<0.0001

Mean age at breast cancer diagnosis (years)

57.5 (±12.4)

58.8 (±16.8)

0.59

Mean tumor size (mm)

21.3 (±11.5)

25.6 (±12.6)

0.05

Proportion of patients with tumor size <21 mm (%)

0.65

0.47

0.06

Proportion of patients with positive lymph nodes (%)

0.37

0.39

0.71

Proportion of patients with grade I (%)

0.23

0.08

0.06a

Proportion of patients with grade II (%)

0.41

0.36

 

Proportion of patients with grade III (%)

0.36

0.56

 

Proportion of patients with estrogen-receptor-positive tumors (%)

0.83

0.79

0.61

Proportion of patients with progesterone-receptor-positive tumors (%)

0.77

0.55

0.01

Proportion of patients receiving chemotherapy (%)

0.18

0.21

0.69

Proportion of patients receiving endocrine therapy (%)

0.76

0.58

0.03

Proportion of patients receiving radiotherapy (%)

0.51

0.39

0.21

  1. Continuous variables compared using t tests; proportions compared using chi-squared tests.
  2. aCombined testing using the chi-squared test.